Medical Stocks To Consider - April 29th

Key Points

• MarketBeat's screener highlights five medical stocks with the highest recent dollar trading volume today: Arcellx (ACLX), UnitedHealth Group (UNH), Eli Lilly (LLY), KalVista (KALV), and AbbVie (ABBV).
• Clinical-stage catalysts could drive volatility: Arcellx is testing its ddCAR candidate anitocabtagene autoleucel in Phase 2 for relapsed/refractory multiple myeloma, while KalVista is developing sebetralstat for hereditary angioedema.
• Large-cap fundamentals underpin investor interest: UnitedHealth combines insurance and Optum services, Eli Lilly has major diabetes and obesity drugs (e.g., Mounjaro, Zepbound), and AbbVie sells multiple established blockbuster therapies.

Arcellx, UnitedHealth Group, Eli Lilly and Company, KalVista Pharmaceuticals, and AbbVie are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies whose primary business is in healthcare, including pharmaceuticals, biotechnology, medical devices, diagnostics, healthcare services and suppliers. Investors view them as a way to gain exposure to the healthcare sector; their value is driven by factors like clinical trial results, regulatory approvals, patent protection, reimbursement policies and demographic trends, which can make them relatively defensive over the long term but volatile around clinical or regulatory events. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

Arcellx (ACLX)

Arcellx, Inc., together with its subsidiary, engages in the development of various immunotherapies for patients with cancer and other incurable diseases in the United States. The company's lead ddCAR product candidate is anitocabtagene autoleucel, which is in phase 2 clinical trial for the treatment of patients with relapsed or refractory multiple myeloma (rrMM).

Read Our Latest Research Report on ACLX

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read Our Latest Research Report on UNH

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Read Our Latest Research Report on LLY

KalVista Pharmaceuticals (KALV)

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs. The company's product candidate is Sebetralstat, a small molecule plasma kallikrein inhibitor targeting the disease of hereditary angioedema (HAE).

Read Our Latest Research Report on KALV

AbbVie (ABBV)

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.

Read Our Latest Research Report on ABBV

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.